Management

aa

Avi Azulai

Partner, UK

Avi Azulai is the founder of a number of companies. One of them, iTouch plc, which he co-founded in 1995 was publicly listed in 2000 on the LSE. iTouch was sold in May 2005 to a Japanese plc. Since then Avi has been actively involved in more startups. One of these was in 2006, Vista Diagnostics, which again he co-founded – a medical practice for visual diagnostics for patients requiring tests such as MRIs & ultra sounds. It was sold in 2009 to a private medical group in the UK. Avi has been involved in the medical industry since 2006, he has been involved in numerous startups in different modalities, building up an experience in many areas of medicine as well as the ways to commercialise the products and services that each is developing. Avi continues to invest and build companies in the hi-tech & medtech space, with the experience of building companies from a very small size to large international & publicly listed companies in excess of $150m turnover. He has a BSc in Computer Science and Applied Mathematics as well as a Diploma in Management. Avi has built his experience in investing in a few companies and building them up to large companies.

aa

David Akunis

Partner, Israel

David Akunis has managed Medvest in Israel since its inception. Previously he served as VP and Investments Manager at ATID Ventures Ltd. Additionally Mr. Akunis served as Private Equity Investment Manager at MEITAV Corporate Finace Ltd. and as the Head of the Medical and Biotech Equipment Department at the Israeli Ministry of Export.

aa

Joaquin Gari

Board Member

Joaquin Gari started investing in start-ups in Israel in 2010, personally investing in Medvest, Rewalk, Higynex, Origin GPS and BondX. In 2012, he founded Tron Capital Partners and Magna Capital, investing in Israel start-ups: Theracoat, Yotpo, Speaking Pal, Webydo, Berimbi, Communitake, Serendip, Ring Ya, Zula and Elevator.

Joaquin was founder and CEO of Derivados del Etilo, S.A., from 1972 to 1996. The company produced amino acids for the pharmaceutical industry and was a leader in this area. The company was sold to DSM in 1996. He was a Board Member of Derivados del Etilo, Banco Español de Crédito, Aerosol Ibérica, Espaclub, etc.